Drug Type Recombinant protein |
Synonyms Lung surfactant factor, Lusupultide (INN/USAN), Recombinant surfactant protein C + [3] |
Target |
Mechanism Lipid inhibitors |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 3 |
First Approval Date- |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D08943 | - | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Respiratory Distress Syndrome, Adult | Phase 3 | US | - | |
Respiratory Distress Syndrome, Adult | Phase 3 | EU | - | |
Respiratory Distress Syndrome, Adult | Phase 3 | CA | - | |
Respiratory Distress Syndrome, Adult | Phase 3 | IL | - | |
Respiratory Distress Syndrome, Adult | Phase 3 | - | - | |
Respiratory Distress Syndrome, Adult | Phase 3 | RU | - | |
Respiratory Distress Syndrome, Adult | Phase 3 | ZA | - | |
Respiratory Distress Syndrome, Adult | Phase 3 | - | - | |
Respiratory Distress Syndrome, Adult | Phase 3 | CH | - | |
Respiratory Distress Syndrome, Adult | Phase 3 | - | - |